Depressive symptoms in Parkinson's disease and in non-neurological medical illnesses

Neuropsychiatric Disease and Treatment

Volumn 9, Issue , 2013, Pages 389-396

  Assogna, Francesca ^a   Fagioli, Sabrina ^a   Cravello, Luca ^a   Meco, Giuseppe ^b   Pierantozzi, Mariangela ^c   Stefani, Alessandro ^c   Imperiale, Francesca ^b   Caltagirone, Carlo ^a,c   Pontieri, Francesco E ^d   Spalletta, Gianfranco ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Depression; Neuropsychiatry; Nonmotor symptoms; Parkinson's disease

Indexed keywords

AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DSM-IV-TR; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINOR DEPRESSIVE DISORDER; PARKINSON DISEASE; PSYCHOLOGIC ASSESSMENT; STRUCTURED INTERVIEW;

EID: 84875472207     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S40013     Document Type: Article

References (42)

1. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992;55(5):377-382.
2. Stern Y, Marder K, Tang MX, Mayeux R. Antecedent clinical features associated with dementia in Parkinson's disease. Neurology. 1993;43(9):1690-1692.
3. Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol. 1996;53(2):175-179.
4. Tandberg E, Larsen JP, Aarsland D, Laake K, Cummings JL. Risk factors for depression in Parkinson disease. Arch Neurol. 1997;54(5): 625-630.
5. Troster AI, Stalp LD, Paolo AM, Fields JA, Koller WC. Neuropsychological impairment in Parkinson's disease with and without depression. Arch Neurol. 1995;52(12):1164-1169.
6. Hobson P, Holden A, Meara J. Measuring the impact of Parkinson's disease quality of life questionnaire. Age Ageing. 1999;28(4): 341-346.
7. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry. 2000;69(3):308-312.
8. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci. 2006;248(1-2):151-157.
9. Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ. Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol. 1990;3(1):3-9.
10. Erdal KJ. Depressive symptom patterns in patients with Parkinson's disease and other older adults. J Clin Psychol. 2001;57(12):1559-1569.
11. Gotham A, Brown R, Marsden C. Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry. 1986;49(4):381-389.
12. Lieberman A. Depression in Parkinson's disease-a review. Acta Neurol Scandinav. 2006;113(1):1-8.
13. Marsh L, McDonald WM, Cummings J, Ravina B; NINDS/NIMH Work Group on Depression and Parkinson's Disease. Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group. Mov Disord. 2006;21(2):148-158.
14. Starkstein SE, Preziosi TJ, Forrester AW, Robinson RG. Specificity of affective and autonomic symptoms of depression in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1990;53(10):869-873.
15. Starkstein SE, Merello M, Jorge R, et al. A validation study of depressive syndromes in Parkinson's disease. Mov Disord. 2008;23(4):538-546.
16. Starkstein SE, Dragovic M, Jorge R, et al. Diagnostic criteria for depression in Parkinson's disease: a study of symptom patterns using latent class analysis. Mov Disord. 2011;26(12):2239-2245.
17. Lou JS, Kearns G, Oken B, Sexton G, Nutt J. Exacerbated physical fatigue and mental fatigue in Parkinson's disease. Mov Disord. 2001; 16(2):190-196.
18. Mergl R, Mavrogiorgou P, Hegerl U, Juckel G. Kinematic analysis of emotionally induced facial expressions: a novel tool to investigate hypomimia in patients suffering depression. J Neurol Neurosurg Psychiatry. 2005;76(1):138-140.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
20. Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry. 2000;15(7):644-649.
21. Leentjens AF, Marinus J, Van Hilten JJ, Lousberg R, Verhey FR. The contribution of somatic symptoms to the diagnosis of depressive disorder in Parkinson's disease: a discriminant analytic approach. J Neuropsychiatry Clin Neurosci. 2003;15(1):74-77.
22. Lyness JM, Bruce ML, Koenig HG, et al. Depression and medical illness in late life: report of a symposium. J Am Geriatr Soc. 1996;44(2): 198-203.
23. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology. 2001;57(8): 1497-1499.
24. Folstein M, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res. 1975;12(3):189-198.
25. Fahn S, Elton RL. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent Developments in Parkinson's Disease. Florham Park, NJ: MacMillan Health Care Information; 1987: 153-304.
26. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord. 1992;7(1):2-13.
27. Beck A, Steer RA. Beck Depression Inventory Manual. San Antonio, TX: The Psychological Corporation; 1987.
28. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62.
29. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77-100.
30. Koenig HG, Cohen HJ, Blazer DG, Ranga Rama Krishnan K, Sibert TE. Profile of depressive symptoms in younger and older medical inpatients with major depression. J Am Geriatr Soc. 1993;41(11):1169-1176.
31. Spalletta G, Troisi A, Saracco M, Ciani N, Pasini A. Symptom profile, Axis II comorbidity and suicidal behaviour in young males with DSM-III-R depressive illnesses. J Affect Disord. 1996;39(2):141-148.
32. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition (SCID-I/P). New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
33. Gasparini M, Spinnler H. Fattening of parkinsonians: a hypothalamic side effect of L-dopa? Med J Aust. 1975;2(15):617.
34. Szczypka MS, Rainey MA, Palmiter RD. Dopamine is required for hyperphagia in Lep(ob/ob) mice. Nat Genet. 2000;25(1):102-104.
35. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature. 2006;443(7109):289-295.
36. Fetissov SO, Meguid MM, Chen C, Miyata G. Synchronized release of dopamine and serotonin in the medial and lateral hypothalamus of rats. Neuroscience. 2000;101(3):657-663.
37. Alam MR, Yoshizawa F, Sugahara K. L-dopa induced extracellular dopamine increases in the ventromedial hypothalamus affects food intake by chickens on a lysine-free diet. Neurosci Lett. 2011;495(2): 126-129.
38. Merschdorf U, Berg D, Csoti I, et al. Psychopathological symptoms of depression in Parkinson's disease compared to major depression. Psychopathology. 2003;36(5):221-225.
39. Schiffer RB, Kurlan R, Rubin A, Boer S. Evidence for atypical depression in Parkinson's disease. Am J Psychiatry. 1988;145(8):1020-1022.
40. Beucke JC, Uhl I, Plotkin M, et al. Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder. World J Biol Psychiatry. 2010;11(6): 781-787.
41. Chaudhuri KR, Schapira A. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8(5):464-474.
42. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry. 2003;54(3):363-375.